Gregory M. C. Orleski
Direktor/Vorstandsmitglied bei 10379085 Canada, Inc.
Aktive Positionen von Gregory M. C. Orleski
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
10379085 Canada, Inc.
 10379085 Canada, Inc. Financial ConglomeratesFinance 10379085 Canada, Inc. is an investment holding Canadian company founded in 2017. The private company is based in Montréal, Canada. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Gregory M. C. Orleski
Ehemalige bekannte Positionen von Gregory M. C. Orleski
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CRESCITA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.09.2016 | 03.11.2016 |
| Vorstandsvorsitzender | 01.09.2016 | 03.11.2016 | |
| ABBOTT INDIA LIMITED | Direktor/Vorstandsmitglied | 21.09.2007 | 21.09.2007 |
Uman Pharma, Inc.
 Uman Pharma, Inc. Pharmaceuticals: GenericHealth Technology Uman Pharma, Inc. develops, manufactures, and markets generic injectable pharmaceutical products. The company was founded in December 20, 2007 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - | - |
INTEGA Skin Sciences, Inc.
 INTEGA Skin Sciences, Inc. Pharmaceuticals: MajorHealth Technology INTEGA Skin Sciences, Inc. is a dermatology company, which offers treatment and care products for skin diseases and their symptoms. The company was founded by Gregory M.C. Orleski in 2015 and is headquartered in Montreal, Canada.^ | Vorstandsvorsitzender | 01.01.2015 | - |
| Gründer | 01.01.2015 | - | |
| Präsident | 01.01.2015 | - | |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Chlorion Pharma, Inc.
 Chlorion Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Chlorion Pharma, Inc. Develops small molecule leads for the treatment of naturopathic pain and epilepsy. It develops therapeutics for the treatment of neuropathic pain and epilepsy. The company was founded by Jeffrey A. M. Coull, Yves De Koninck and Martin Gagnon in 2004 and is headquartered in Laval, Canada. | Vorsitzender | 15.10.2009 | - |
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - | - |
Ausbildung von Gregory M. C. Orleski
| McGill University | Graduate Degree |
| University of Alberta | Undergraduate Degree |
Statistik
International
| Kanada | 9 |
| Vereinigte Staaten | 2 |
| Indien | 2 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ABBOTT INDIA LIMITED | Health Technology |
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Uman Pharma, Inc.
Uman Pharma, Inc. Pharmaceuticals: GenericHealth Technology Uman Pharma, Inc. develops, manufactures, and markets generic injectable pharmaceutical products. The company was founded in December 20, 2007 and is headquartered in Montreal, Canada. | Health Technology |
INTEGA Skin Sciences, Inc.
INTEGA Skin Sciences, Inc. Pharmaceuticals: MajorHealth Technology INTEGA Skin Sciences, Inc. is a dermatology company, which offers treatment and care products for skin diseases and their symptoms. The company was founded by Gregory M.C. Orleski in 2015 and is headquartered in Montreal, Canada.^ | Health Technology |
10379085 Canada, Inc.
10379085 Canada, Inc. Financial ConglomeratesFinance 10379085 Canada, Inc. is an investment holding Canadian company founded in 2017. The private company is based in Montréal, Canada. | Finance |
Chlorion Pharma, Inc.
Chlorion Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Chlorion Pharma, Inc. Develops small molecule leads for the treatment of naturopathic pain and epilepsy. It develops therapeutics for the treatment of neuropathic pain and epilepsy. The company was founded by Jeffrey A. M. Coull, Yves De Koninck and Martin Gagnon in 2004 and is headquartered in Laval, Canada. | Commercial Services |
- Börse
- Insiders
- Gregory M. C. Orleski
- Erfahrung
